Rilastil reaffirms its commitment to dermatology at EADV Paris 2025

In addition to its outstanding participation in EADV, Rilastil was also present at GEDET, where it organized the symposium entitled: “From super-specialization to integration: a new approach to women's health”

02 of October of 2025
Save
NIB Artículosentradas a retocar   2025 10 02T085621.372
NIB Artículosentradas a retocar 2025 10 02T085621.372

From September 17 to 20, 2025, Rilastil, a leading Italian dermatological brand, participated in the European Academy of Dermatology and Venereology (EADV) Congress, held in Paris.

This event brings together thousands of health professionals from around the world to discuss the latest scientific and technological advances in dermatology.

Rilastil's presence at EADV 2025 responds to a clear objective: to be close to the dermatologist, listen to them and support them to cover the real needs of their patients. In an environment where innovation and medical knowledge are advancing rapidly, Rilastil wants to be an active and committed ally with those who are on the front line of skin care.

EADV is much more than a congress, it is a space for dialogue, inspiration and collaboration. At Rilastil we believe that only by walking alongside the dermatologist can we lead the future of dermatology together”, highlighted Anahí Gil, Head of Marketing.

In addition to its outstanding participation in EADV, Rilastil was also present at GEDET, where it organized the symposium entitled: “From super-specialization to integration: a new approach to women's health”. During this meeting, the importance of creating bridges between medical specialties to work on women's health in a more personalized, comprehensive and ultra-specialized way was addressed, with a special focus on the different stages of menopause.

The symposium included the participation of renowned experts:

  • Dr. Juan Gavín, dermatologist
  • Dr. María Fasero, gynecologist
  • Dr. María Martínez Villaescusa, nephrologist

This multidisciplinary space reflected Rilastil's commitment to a vision of medicine focused on women and collaboration between professionals to offer innovative and effective solutions.

Participation in both events reinforces Rilastil's strategy to continue developing effective, safe and science-based dermatological solutions, always hand in hand with specialists.